What is Andel?
Andel operates as a transformative cooperative employee platform dedicated to unlocking access to high-cost medications, specifically GLP-1s and other brand-name drugs. By positioning itself as a bridge between pharmaceutical manufacturers and the workforce, Andel addresses the critical issue of drug affordability through a collective bargaining and access-oriented framework. The company's market position is defined by its ability to navigate complex healthcare regulations while providing tangible value to employees who are otherwise priced out of essential treatments. As the healthcare sector faces increasing scrutiny over pricing transparency, Andel's model offers a scalable solution that aligns corporate interests with patient accessibility.
How much funding has Andel raised?
Andel has raised a total of $4.5M across 1 funding round:
Other Financing Round
$4.5M
Other Financing Round (2025): $4.5M with participation from Seedcamp, Lightbank, and Bertelsmann SE
Key Investors in Andel
Seedcamp
Seedcamp is a venture capital firm that supports early-stage startups by providing investment, mentorship, and access to a global network. The firm focuses on ambitious founders and innovative companies across various sectors, helping them grow from initial concepts to successful businesses.
Lightbank
Lightbank is an investment firm based in Chicago, IL, focusing on funding innovative startups. The company aims to support entrepreneurs by providing capital and strategic guidance to help them scale their operations.
Bertelsmann SE
Bertelsmann is a global media and services company that operates an international network of funds through Bertelsmann Investments. They focus on fostering growth and innovation across diverse sectors, including education and digital services.
What's next for Andel?
Looking ahead, Andel is focused on the operational execution of its nationwide rollout scheduled for 2026. The current enterprise-level funding will be directed toward enhancing the platform's technological capabilities and expanding its network of employer partners. By prioritizing the integration of its cooperative model into existing benefits packages, Andel intends to capture a significant share of the medication access market. The strategic roadmap emphasizes long-term sustainability and the expansion of its formulary to include a broader range of essential medications, ensuring that the company remains at the forefront of the movement to democratize healthcare access for the modern workforce.
See full Andel company page
